Viracept and Thrombophlebitis - a phase IV clinical study of FDA data

Summary:

Thrombophlebitis is reported as a side effect among people who take Viracept (nelfinavir mesylate), especially for people who are female, 20-29 old, have been taking the drug for 1 - 6 months also take Epivir, and have Hiv test positive.

The phase IV clinical study analyzes which people have Thrombophlebitis when taking Viracept. It is created by eHealthMe based on reports of 6,392 people who have side effects when taking Viracept from the FDA, and is updated regularly.

What is Viracept?

Viracept has active ingredients of nelfinavir mesylate. It is often used in hiv infection. eHealthMe is studying from 6,399 Viracept users. Check the latest studies of Viracept.

What is Thrombophlebitis?

Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot) is found to be associated with 944 drugs and 1,267 conditions by eHealthMe. Check the latest studies of Thrombophlebitis.

On Jul, 14, 2026

6,392 people reported to have side effects when taking Viracept.
Among them, 17 people (0.27%) have Thrombophlebitis.

Among these 17 people:

How long have people been on Viracept when they have Thrombophlebitis? *

What is the gender of people who have Thrombophlebitis when taking Viracept? *

female: 76.47 %
male: 23.53 %

What is the age of people who have Thrombophlebitis when taking Viracept? *

What are other drugs people take besides Viracept? *

What are other side effects people have besides Thrombophlebitis? *

Stillbirth (a birth of dead foetus): 11 people, 64.71%
Funisitis (infection of the connective tissue of the umbilical cord): 10 people, 58.82%
Drug Exposure During Pregnancy: 7 people, 41.18%
Neonatal Aspiration (aspiration by neonate): 7 people, 41.18%
Chorioamnionitis (inflammation of the fetal membranes (amnion and chorion) due to a bacterial infection): 6 people, 35.29%
Placental Disorder: 5 people, 29.41%
Anaemia (lack of blood): 4 people, 23.53%
Cranial Sutures Widening: 4 people, 23.53%
Placental Insufficiency: 4 people, 23.53%
Birth Control: 4 people, 23.53%

What are the existing conditions these people have? *

Hiv Test Positive: 4 people, 23.53%
Herpes Simplex (herpes simplex is a common viral infection): 3 people, 17.65%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Viracept and have Thrombophlebitis?

- Check whether Thrombophlebitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Viracept:

Viracept (6,399 reports)

Thrombophlebitis treatments and more:

Thrombophlebitis (13,501 reports)

Browse all side effects of Viracept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombophlebitis:

Thrombophlebitis (944 drugs)

Browse all the conditions that are associated with Thrombophlebitis:

Thrombophlebitis (1,267 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nelfinavir mesylate (the active ingredients of Viracept) and Viracept (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.